Today, we announced the initiation of the EMBO-02 clinical study of NeoCast? to treat chronic subdural hematomas (cSDH). EMBO-02 will enroll up to 10 subjects at three sites in Australia, and the first patient has already been enrolled at Monash Health. Learn more about NeoCast, a first-of-its-kind, shear-responsive, non-adhesive, solvent-free, liquid #embolic material designed for deep distal penetration: https://lnkd.in/gF54fWXV ? #Biomaterials #Neurovascular Lee-Anne Slater
关于我们
Arsenal Medical is a clinical-stage company that develops biomaterials to solve challenging and underserved medical problems. It was founded by serial entrepreneur-investor Carmichael Roberts and academic luminaries Robert Langer and George Whitesides, who shared a vision for how materials can transform medicine. The company’s foundational product, ResQFoam, is a life-saving intervention that addresses non-compressible intra-abdominal hemorrhage in trauma patients. It has been designated a breakthrough device by the FDA.
- 网站
-
https://arsenalmedical.com/
Arsenal Medical的外部链接
- 所属行业
- 医疗设备
- 规模
- 11-50 人
- 总部
- Waltham，Massachusetts
- 类型
- 私人持股
地点
-
主要
获取路线
100 Beaver St
Suite 302
US，Massachusetts，Waltham，02453
Arsenal Medical员工
动态
-
We are honored to be among a fantastic group of finalists for the 2024 MedTech Innovator Mid-Stage Competition. If you plan to attend the MedTech Strategist Innovation Summit in San Diego, please reach out to set up a time or come and see our CEO, Upma Sharma, PhD, present the Arsenal story on November 20th. ?#InnovationSanDiego
Announcing the 2024?MedTech Innovator?Mid-Stage Grand Finalists & Value Award Finalists! ?? This year’s Mid-Stage cohort includes outstanding medtech companies focused on transformative healthcare impact. Congratulations to the finalists competing for the $200k non-dilutive prize:?Arsenal Medical,?LATTICE MEDICAL,?Ozlo Sleep, and?Somnics, Inc.. This year’s MedTech Innovator Value Award, a $25,000 prize, is the culmination of MTI's comprehensive Value Program, a unique accelerator component where companies refine their value propositions with guidance from market access coaches. The finalists:?Cellular Vehicles,?CranioSense,?iCE Neurosystems, Inc., and?myBiometry. Congrats to these trailblazers - stay tuned and be involved at the?MedTech Strategist?Innovation Summit in San Diego, CA Nov 19-21, where both competitions will be held and winners will be crowned after a live audience vote. ?? Check out the press release here: https://lnkd.in/gi-bqX7H #medicaldevice #medtech #innovation #MTS24
-
-
We are excited to share that our CEO, Upma Sharma, PhD, will participate in two powerhouse panels at The MedTech Conference this week. #MTC24 #MedTechCon
I’m honored to be a speaker at The MedTech Conference on October 15-17 in Toronto! I will be bookending the conference with two great panels: Monday 4:30pm: AdvaMed WEN Program: Beyond Boundaries - Empowering Women in Entrepreneurship Across Industries moderated by Sheila Shah and co-panelists Julia Strandberg, Nada (Osman) Hanafi, and Holly Sheffield Thursday 9:40am: Innovative Materials - MedTech Material Girls moderated by Nicole Black, PhD with co-panelists (Kristine Mechem, Stephanie Juniat, Nicolette Driscoll, and Peter Stebbins) Hope to see you there! #MedTechCon #MTC24 Arsenal Medical
-
-
We are grateful to Dr. Laetitia de Villiers for presenting NeoCast’s first-in-human results at our first WFITN Congress. Gold Coast University Hospital, Jeffrey Groom II, Upma Sharma, PhD WFITN NEW YORK #biomaterials #NeoCast
-
-
We are pleased to be featured in the MD+DI Let's Talk Medtech podcast. Learn more about our story from our CEO, Upma Sharma, PhD.
Thanks to Omar Ford and MD+DI for inviting me to Let’s Talk Medtech. It was a fun opportunity to share a bit about Arsenal Medical’s work creating innovative biomaterials as medical devices and to share a bit about my own professional journey!
-
Thanks to MedTech Innovator and to the Arsenal Team who worked to create our video. Upma Sharma, PhD PhD Jeffrey Groom II Quynh Pham #MTIBestVideo
Arsenal Medical is developing innovative biomaterials as transformative medical devices, such as a next generation embolic for neurovascular conditions or a life-saving foam to treat abdominal hemorrhage. Watch their pitch video & like it on YouTube to vote for them to win the $10K #MTIBestVideo Upma Sharma, PhD https://lnkd.in/gBBSrkKR
Arsenal Medical: 2024 MTI Best Video Competition
https://www.youtube.com/
-
We are honored to be part of #ESMINT this year. Special thanks to Lee-Anne Slater and Adam Arthur; we appreciate your work and presentations on NeoCast. Upma Sharma, PhD Jeffrey Groom II Monash Health #ESMINT2024
It has been an exciting week in Marseille at the European Society of Minimally Invasive Neurological Therapy Congress! Thank you to Drs. Adam Arthur and Lee-Anne Slater for their presentations today on Arsenal Medical’s NeoCast, a next-generation, solvent-free, deep-penetrating embolic material. We are proud to have the opportunity to share these pre-clinical and clinical results with the European Neurointerventional community. ?? ? #Biomaterials #NeoCast #ESMINT2024 Department of Neurosurgery, Monash Health
-
-
Last week we announced that the?open-label, multicenter, prospective?EMBO-01 clinical trial of NeoCast met its primary feasibility and safety endpoints. The study demonstrated predictable and well-controlled vascular occlusion with #NeoCast, a shear-responsive liquid #embolic material designed for deep distal penetration into the microvasculature. Read more about the late-breaking first-in-human results in Endovascular Today's article: https://lnkd.in/ezgsgGPz ? #Biomaterials #SNIS #SNIS2024 Upma Sharma, PhD Lee-Anne Slater David Fiorella, MD
-
-
?“NeoCast has the potential to be a game-changer for liquid embolics.” – Lee-Anne Slater, MBBS MMed FRANZCR, Interventional Neuroradiologist at Monash Health and the principal investigator for the EMBO-01 trial ? We’re thrilled to announce that NeoCast, a first-of-its-kind, shear-responsive liquid #embolic material designed for deep distal penetration, met its primary feasibility and safety endpoints in the open-label, multi-center, prospective, EMBO-01 clinical trial.?https://lnkd.in/eUm4pPXc #Biomaterial #Neurovascular #SNIS #SNIS2024 Upma Sharma, PhD
Arsenal Medical Announces Late-Breaking Results from First-in-Human Clinical Trial of NeoCast? at the Society of Neurointerventional Surgery Annual Meeting | MedTech Dive
medtechdive.com
-
We are excited to share that Arsenal Medical has been selected as a spoke of the?Investor Catalyst Hub network. VentureWell Advanced Research Projects Agency for Health (ARPA-H) Upma Sharma, PhD
-